Sandbox vidit: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{{familytree | | | B01 | | | | | | B02 | | | | | | |B01=Unstable |B02=Stable }} | {{familytree | | | B01 | | | | | | B02 | | | | | | |B01=Unstable |B02=Stable }} | ||
{{familytree | | | |!| | | | | | | |!| | | | | | | | }} | {{familytree | | | |!| | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | C01 | | | | | | C02 | | | | | | |C01=<div style="float: left; text-align: left; padding:1em;">❑ Look for the presence of any of these: <br> | {{familytree | | | C01 | | | | | | C02 | | | | | | |C01=<div style="float: left; text-align: left; width:25em; padding:1em;">❑ Look for the presence of any of these: <br> | ||
:❑ Chronic heart failure | :❑ Chronic heart failure | ||
:❑ Hypotension | :❑ Hypotension | ||
:❑ Acute myocardial infarction <br> | :❑ Acute myocardial infarction <br> | ||
</div>|C02=<div style="float: left; text-align: left; padding:1em;"> ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours <br> ❑ Administer rate control therapy (AV nodal blockers) <br><br> ''THEN'' <br><br>❑ Attempt conversion | </div>|C02=<div style="float: left; text-align: left; width:25em; padding:1em;"> ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours <br> ❑ Administer rate control therapy (AV nodal blockers) <br><br> ''THEN'' <br><br>❑ Attempt conversion | ||
:❑ DC cardioversion | :❑ DC cardioversion | ||
:❑ Atrial pacing | :❑ Atrial pacing | ||
Line 14: | Line 14: | ||
</div> }} | </div> }} | ||
{{familytree | | | |`|-|-|-|v|-|-|-|'| | | | | | | | }} | {{familytree | | | |`|-|-|-|v|-|-|-|'| | | | | | | | }} | ||
{{familytree | | | | | | | D01 | | | | | | | | | | |D01=<div style="float: left; text-align: left; padding:1em;"> ❑ Assess need for therapy to prevent recurrence </div> |D02=}} | {{familytree | | | | | | | D01 | | | | | | | | | | |D01=<div style="float: left; text-align: left; width:25em; padding:1em;"> ❑ Assess need for therapy to prevent recurrence </div> |D02=}} | ||
{{familytree | | | | | | | |!| | | | | | | | | | | | }} | {{familytree | | | | | | | |!| | | | | | | | | | | | }} | ||
{{familytree | | | | | | | E01 | | | | | | | | | | |E01=<div style="float: left; text-align: left; padding:1em;"> ❑ Administer antiarrythmic therapy to prevent recurrences | {{familytree | | | | | | | E01 | | | | | | | | | | |E01=<div style="float: left; text-align: left; width:25em; padding:1em;"> ❑ Administer antiarrythmic therapy to prevent recurrences | ||
---- | ---- | ||
❑ Consider catheter ablation if antiarrhythmic therapy fails </div>}} | ❑ Consider catheter ablation if antiarrhythmic therapy fails </div>}} |
Revision as of 19:05, 10 March 2014
Atrial flutter | |||||||||||||||||||||||||||||||||||||||
Unstable | Stable | ||||||||||||||||||||||||||||||||||||||
❑ Look for the presence of any of these:
| ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours ❑ Administer rate control therapy (AV nodal blockers) THEN ❑ Attempt conversion
| ||||||||||||||||||||||||||||||||||||||
❑ Assess need for therapy to prevent recurrence | |||||||||||||||||||||||||||||||||||||||
❑ Administer antiarrythmic therapy to prevent recurrences
❑ Consider catheter ablation if antiarrhythmic therapy fails | |||||||||||||||||||||||||||||||||||||||
Anticoagulation Therapy
Shown below are tables depicting the assessment of risk of stroke and the appropriate anticoagulation therapy among patients with Atrial flutter.[1]
|
Low Risk Factors | Moderate Risk Factors | High Risk Factors |
▸ Female gender ▸ Age 65-74 years ▸ Coronary artery disease ▸ Thyrotoxicosis |
▸ Age ≥ 75 years ▸ Hypertension ▸ Heart failure ▸ LV ejection fraction ≤ 35% ▸ Diabetes mellitus |
▸ Previous stroke, TIA or embolism ▸ Mitral stenosis ▸ Prosthetic heart valve |
Acute management of atrial flutter
|
Long term management of atrial flutter
|
- ↑ Fuster, V.; Rydén, LE.; Cannom, DS.; Crijns, HJ.; Curtis, AB.; Ellenbogen, KA.; Halperin, JL.; Kay, GN.; Le Huezey, JY. (2011). "2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 123 (10): e269–367. doi:10.1161/CIR.0b013e318214876d. PMID 21382897. Unknown parameter
|month=
ignored (help)